PCOS Challenge Criticizes Global Renaming of Polycystic Ovary Syndrome
The National Polycystic Ovary Syndrome Association (PCOS Challenge) has criticized a global consensus effort to rename PCOS as polyendocrine metabolic ovarian syndrome (PMOS), arguing the process lacked sufficient evidence and ethical standards. The organization acknowledges potential issues with the current name but emphasizes that renaming alone may not address systemic healthcare challenges such as delayed diagnosis, inconsistent care, or research underinvestment.
Topics: medical terminology patient advocacy PCOS PMOS